Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial

[1]  R. Tandoğan,et al.  Intra-articular zoledronic acid in a rat osteoarthritis model: significant reduced synovitis may indicate chondroprotective effect , 2015, Knee Surgery, Sports Traumatology, Arthroscopy.

[2]  C. Christiansen,et al.  The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments? , 2013, Annals of the rheumatic diseases.

[3]  S. Adami,et al.  Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells , 2013, Calcified Tissue International.

[4]  D. Walsh,et al.  Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis , 2013, Annals of the rheumatic diseases.

[5]  L. Laslett,et al.  Effect of bisphosphonate use in patients with symptomatic and radiographic knee osteoarthritis: data from the Osteoarthritis Initiative , 2013, Annals of the rheumatic diseases.

[6]  L. Idolazzi,et al.  Treatment of complex regional pain syndrome type I with neridronate : a randomized , double-blind , placebo-controlled study , 2013 .

[7]  C. Cooper,et al.  Extended report: Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial , 2013 .

[8]  L. Idolazzi,et al.  Long-Term Effects of Amino-Bisphosphonates on Circulating γδ T Cells , 2012, Calcified Tissue International.

[9]  A. Rutjes,et al.  Viscosupplementation for Osteoarthritis of the Knee , 2012, Annals of Internal Medicine.

[10]  M. Doschak,et al.  Potential mechanism of alendronate inhibition of osteophyte formation in the rat model of post-traumatic osteoarthritis: evaluation of elemental strontium as a molecular tracer of bone formation. , 2012, Osteoarthritis and cartilage.

[11]  Gordon Guyatt,et al.  American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee , 2012, Arthritis care & research.

[12]  Douglas Wardlaw,et al.  Alternative analyses for handling incomplete follow-up in the intention-to-treat analysis: the randomized controlled trial of balloon kyphoplasty versus non-surgical care for vertebral compression fracture (FREE) , 2012, BMC Medical Research Methodology.

[13]  R. Nizard,et al.  Targeting Bone Alleviates Osteoarthritis in Osteopenic Mice and Modulates Cartilage Catabolism , 2012, PloS one.

[14]  L. Laslett,et al.  Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial , 2012, Annals of the rheumatic diseases.

[15]  G. Herrero-Beaumont,et al.  Bone mineral density and joint cartilage: four clinical settings of a complex relationship in osteoarthritis , 2011, Annals of the rheumatic diseases.

[16]  K. Rose,et al.  Interaction of clodronate with fibroblast growth factor 2 reduces FGF2-activity in endothelial cells. , 2011, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[17]  Raveendhara R. Bannuru,et al.  Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis--meta-analysis. , 2010, Osteoarthritis and cartilage.

[18]  T. Huizinga,et al.  Do knee abnormalities visualised on MRI explain knee pain in knee osteoarthritis? A systematic review , 2010, Annals of the rheumatic diseases.

[19]  Z.-M. Zhang,et al.  Micro-CT and mechanical evaluation of subchondral trabecular bone structure between postmenopausal women with osteoarthritis and osteoporosis , 2010, Osteoporosis International.

[20]  F. Cicuttini,et al.  Subchondral bone and cartilage damage: a prospective study in older adults. , 2010, Arthritis and rheumatism.

[21]  O. Simonsen,et al.  Intra-articular hyaluronan is without clinical effect in knee osteoarthritis: a multicentre, randomised, placebo-controlled, double-blind study of 337 patients followed for 1 year , 2010, Annals of the rheumatic diseases.

[22]  B. Abrahamsen.  Adverse Effects of Bisphosphonates , 2010, Calcified Tissue International.

[23]  P Tugwell,et al.  OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. , 2010, Osteoarthritis and cartilage.

[24]  S. Goldring,et al.  Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis , 2010, Annals of the New York Academy of Sciences.

[25]  S. Jimenez,et al.  Primary osteoarthritis no longer primary: three subsets with distinct etiological, clinical, and therapeutic characteristics. , 2009, Seminars in arthritis and rheumatism.

[26]  I. Olivieri,et al.  Intra-articular clodronate for the treatment of knee osteoarthritis: dose ranging study vs hyaluronic acid. , 2009, Rheumatology.

[27]  D. English,et al.  The natural history of bone marrow lesions in community-based adults with no clinical knee osteoarthritis , 2008, Annals of the rheumatic diseases.

[28]  P. Dieppe,et al.  The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials , 2008, Annals of the rheumatic diseases.

[29]  M. Pappagallo,et al.  Complex Regional Pain Syndrome (CRPS/RSD) and Neuropathic Pain: Role of Intravenous Bisphosphonates as Analgesics , 2008, TheScientificWorldJournal.

[30]  M. Nevitt,et al.  The effect of alendronate on progression of spinal osteophytes and disc-space narrowing , 2008, Annals of the rheumatic diseases.

[31]  E. Fallentin,et al.  Intra‐articular sodium hyaluronate 2 mL versus physiological saline 20 mL versus physiological saline 2 mL for painful knee osteoarthritis: a randomized clinical trial , 2008, Scandinavian journal of rheumatology.

[32]  A. Rutjes,et al.  Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis. , 2007, Arthritis and rheumatism.

[33]  H. Fleisch.  [Introduction to bisphosphonates. History and functional mechanisms]. , 2007, Der Orthopade.

[34]  H. Fleisch.  Einführung in die Bisphosphonate , 2007, Der Orthopäde.

[35]  T. Spector,et al.  Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. , 2006, Arthritis and rheumatism.

[36]  G. Herrero-Beaumont,et al.  Cartilage oligomeric matrix protein (COMP) is modified by intra-articular liposomal clodronate in an experimental model of arthritis. , 2006, Clinical and experimental rheumatology.

[37]  Craig R Denegar,et al.  Knee osteoarthritis: should your patient opt for hyaluronic acid injection? , 2006, The Journal of family practice.

[38]  G. H. Nancollas,et al.  Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. , 2006, Bone.

[39]  N. Bellamy,et al.  Viscosupplementation for the treatment of osteoarthritis of the knee. , 2006, The Cochrane database of systematic reviews.

[40]  M. Müllner,et al.  Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis , 2005, Canadian Medical Association Journal.

[41]  T. Spector,et al.  Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173] , 2005, Arthritis Research & Therapy.

[42]  David Felson,et al.  The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis. , 2004, Arthritis and rheumatism.

[43]  H. Korf,et al.  Clodronate inhibits the secretion of proinflammatory cytokines and NO by isolated microglial cells and reduces the number of proliferating glial cells in excitotoxically injured organotypic hippocampal slice cultures , 2004, Experimental Neurology.

[44]  L. Duong,et al.  The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. , 2004, Arthritis and rheumatism.

[45]  S. Hou,et al.  Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. , 2004, The Journal of bone and joint surgery. American volume.

[46]  D. Felson,et al.  Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. , 2003, JAMA.

[47]  Arden,et al.  EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) , 2003, Annals of the rheumatic diseases.

[48]  A. Hall,et al.  The volume and morphology of chondrocytes within non-degenerate and degenerate human articular cartilage. , 2003, Osteoarthritis and cartilage.

[49]  E. Thonar,et al.  The effect of bone remodeling inhibition by zoledronic acid in an animal model of cartilage matrix damage. , 2002, Osteoarthritis and cartilage.

[50]  J. Mönkkönen,et al.  The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis. , 2001, Arthritis and rheumatism.

[51]  R. McCarney,et al.  Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care , 2001, Annals of the rheumatic diseases.

[52]  J. Beijnen,et al.  Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[53]  M. Zanetti,et al.  Bone marrow edema pattern in osteoarthritic knees: correlation between MR imaging and histologic findings. , 2000, Radiology.

[54]  T. Salo,et al.  MMP Inhibition and Downregulation by Bisphosphonates , 1999, Annals of the New York Academy of Sciences.

[55]  D. Nelson,et al.  Periarticular osteoporosis in osteoarthritis of the knee. , 1998, The Journal of rheumatology.

[56]  A. G. Bergman,et al.  Osteoarthritis of the knee: correlation of subchondral MR signal abnormalities with histopathologic and radiographic features , 1994, Skeletal Radiology.

[57]  Bergman Ag,et al.  Case report 841 , 1994 .

[58]  P. Tugwell,et al.  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. , 1990, Arthritis and rheumatism.

[59]  C. Goldsmith,et al.  Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. , 1988, The Journal of rheumatology.

[60]  R. Moskowitz,et al.  Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. , 1986, Arthritis and rheumatism.

[61]  温春毅,et al.  Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis , 2013 .

[62]  Ali Guermazi,et al.  Central bone marrow lesions in symptomatic knee osteoarthritis and their relationship to anterior cruciate ligament tears and cartilage loss. , 2008, Arthritis and rheumatism.

[63]  C. Buckland-Wright,et al.  Cancellous bone differences between knees with early, definite and advanced joint space loss; a comparative quantitative macroradiographic study. , 2005, Osteoarthritis and cartilage.

[64]  N. Bellamy,et al.  Intraarticular corticosteroid for treatment of osteoarthritis of the knee. , 2005, The Cochrane database of systematic reviews.

[65]  Seiko F. Okada,et al.  Analgesic effect of etidronate on degenerative joint disease , 2001, Journal of Bone and Mineral Metabolism.

[66]  M. Lequesne,et al.  Indexes of severity for osteoarthritis of the hip and knee. Validation--value in comparison with other assessment tests. , 1987, Scandinavian journal of rheumatology. Supplement.